Anxiety in Patients Treated with Hemodialysis

被引:125
作者
Cohen, Scott D. [1 ]
Cukor, Daniel [2 ]
Kimmel, Paul L. [1 ,3 ]
机构
[1] George Washington Univ, Med Ctr, Dept Med, Div Renal Dis & Hypertens, Washington, DC 20037 USA
[2] Suny Downstate Med Ctr, Dept Psychiat & Behav Sci, Brooklyn, NY 11203 USA
[3] NIDDK, Div Kidney Urol & Hematol Dis, NIH, Bethesda, MD 20892 USA
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2016年 / 11卷 / 12期
关键词
QUALITY-OF-LIFE; STAGE RENAL-DISEASE; CHRONIC KIDNEY-DISEASE; DEPRESSION; DISORDERS; THERAPY; HEALTH; IMPAIRMENT; PREVALENCE; OUTCOMES;
D O I
10.2215/CJN.02590316
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Anxiety is a common yet frequently overlooked psychiatric symptom in patients with ESRD treated with hemodialysis (HD). Anxiety is characterized by disruptive feelings of uncertainty, dread, and fearfulness. A variety of common medical complaints may be manifestations of an anxiety disorder, including palpitations, tremors, indigestion, numbness/tingling, nervousness, shortness of breath, diaphoresis, and fear. It is essential for the clinician to rule out specific medical conditions, including cardiovascular, pulmonary, and neurologic diseases, before ascribing these symptoms to an anxiety disorder. In addition, there is considerable overlap between the symptoms of anxiety and those of depression and uremia. This psychiatric condition has a significant adverse impact on patients' perception of quality of life. Little is known regarding the prevalence and impact of anxiety disorders in patients with ESRD treated with HD; however, many of the seemingly irrational behaviors of patients, or behaviors which place them in conflict with staff and physicians, such as behavioral noncompliance, may be the expression of an underlying anxiety disorder. In this review, we present three clinical vignettes, highlighting the impact of anxiety disorders in patients with ESRD treated with HD.
引用
收藏
页码:2250 / 2255
页数:6
相关论文
共 33 条
[1]  
[Anonymous], COGN BRAIN BEHAV
[2]   Evidence-Based Review of Clinical Outcomes of Guideline-Recommended Pharmacotherapies for Generalized Anxiety Disorder [J].
Bereza, Basil G. ;
Machado, Marcio ;
Ravindran, Arun V. ;
Einarson, Thomas R. .
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2012, 57 (08) :470-478
[3]   Clinical, Sociodemographic, and Psychological Correlates of Health-Related Quality of Life in Chronic Hemodialysis Patients [J].
Birmele, Beatrice ;
Le Gall, Armel ;
Sautenet, Benedicte ;
Aguerre, Colette ;
Camus, Vincent .
PSYCHOSOMATICS, 2012, 53 (01) :30-37
[4]  
Carter MJ, 2014, THER RECREAT J, V48, P275
[5]   COGNITIVE THERAPY OF ANXIETY DISORDERS [J].
CHAMBLESS, DL ;
GILLIS, MM .
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1993, 61 (02) :248-260
[6]   Psychological treatment of generalized anxiety disorder: A meta-analysis [J].
Cuijpers, Pim ;
Sijbrandij, Marit ;
Koole, Sander ;
Huibers, Marcus ;
Berking, Matthias ;
Andersson, Gerhard .
CLINICAL PSYCHOLOGY REVIEW, 2014, 34 (02) :130-140
[7]   Course of Depression and Anxiety Diagnosis in Patients Treated with Hemodialysis: A 16-month Follow-up [J].
Cukor, Daniel ;
Coplan, Jeremy ;
Brown, Clinton ;
Peterson, Rolf A. ;
Kimmel, Paul L. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 (06) :1752-1758
[8]   Anxiety disorders in adults treated by hemodialysis: A single-center study [J].
Cukor, Daniel ;
Coplan, Jeremy ;
Brown, Clinton ;
Friedman, Steven ;
Newville, Howard ;
Safier, Michal ;
Spielman, Lisa A. ;
Peterson, Rolf A. ;
Kimmel, Paul L. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 52 (01) :128-136
[9]   Psychosocial aspects of chronic disease: ESRD as a paradigmatic illness [J].
Cukor, Daniel ;
Cohen, Scott D. ;
Peterson, Rolf A. ;
Kimmel, Paul L. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (12) :3042-3055
[10]   Depression in end-stage renal disease hemodialysis patients [J].
Cukor, Daniel ;
Peterson, Rolf A. ;
Cohen, Scott D. ;
Kimmel, Paul L. .
NATURE CLINICAL PRACTICE NEPHROLOGY, 2006, 2 (12) :678-687